$26.48
-0.28-1.05%
Last update: Nov 11, 4:11 PM
Elanco Animal Health Inc
ELANNYSE
Elanco Animal Health rose 15.8% from $22.86 to $26.48, ahead of the S&P 500's +11.2%. Its worst day was Aug 7 (−8.6%), and its low came May 19 at $19.80.
Nov 11, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.13 beat the $0.11 estimate on $1.1B revenue (est. $1.1B); Q1 revenue guidance of $1.3B–$1.3B against the $1.3B consensus.
+6.6% · S&P 500 +0.7%
Story events cover the past 12 months · Times ET
Elanco Animal Health shares rose 7.6%, while the S&P 500 rose 0.3%.
+7.6% · S&P 500 +0.3%
EPS of $0.40 beat the $0.34 estimate on $1.4B revenue (est. $1.3B); Q2 revenue guidance of $1.3B–$1.3B against the $1.3B consensus.
+13.9%, the year's best day · S&P 500 +1.4%
Elanco Animal Health closed at its lowest level of the year, 13.4% below where the year started.
−0.7% · S&P 500 −0.7%
EPS of $0.34 beat the $0.27 estimate on $1.4B revenue (est. $1.3B); Q3 revenue guidance of $1.2B–$1.2B against the $1.2B consensus.
+2.4% · S&P 500 −0.2%
EPS of $0.27 beat the $0.20 estimate on $1.3B revenue (est. $1.2B); Q4 revenue guidance of $1.2B–$1.2B against the $1.2B consensus.
+8.7% · S&P 500 +0.3%
Where it ended: a close of $26.48 on Nov 11, 2026. Up next: Q4 2026 earnings on Feb 23, 2027 (EPS est. $0.17, revenue est. $1.2B).
Nothing in the past 12 months.
All ELAN dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ELAN and SPY from Benzinga historical bars. Not investment advice.
